Scholarly Colloquia and Events

  • 12/4 Dept. of Pharm Sci Seminar: Dr. Jonathan Miller

    Pharmaceutics Graduate Seminar

     

    Jonathan Miller, Ph.D. 

    Executive Director, Kymera Therapeutics.

     

    Seminar Title: “The Solubility-Permeability Interplay:  Implications for Formulation Design and In-Vivo Performance”

     

    PBB 338

    Friday December 4th, 2026, from 12:15 pm – 1:30 pm

     

    Jonathan Mark Miller, Ph.D. is Executive Director of Formulation and Process Development at Kymera Therapeutics, where he leads formulation and process development activities supporting programs from Phase I through commercialization. Dr. Miller is a pharmaceutical scientist with nearly three decades of industry experience spanning drug discovery, development, and commercialization, having held scientific and leadership roles at Kymera Therapeutics, Vertex Pharmaceuticals, AbbVie, and Pfizer.

     

    His expertise includes formulation development for poorly soluble compounds, amorphous solid dispersions, lipid-based drug delivery systems, modified-release formulations, biopharmaceutics, and physiologically based pharmacokinetic (PBPK) modeling. During his career, he has contributed to the development and regulatory approval of several significant therapies, including products for cystic fibrosis and hepatitis C, and is an inventor on numerous patents in drug delivery and pharmaceutical formulation.

     

    Dr. Miller earned his Ph.D. in Pharmaceutical Sciences from the University of Michigan.

    He has authored more than 40 scientific publications and is a frequent invited speaker on oral drug delivery, bioavailability enhancement, and formulation science.

    For more information, contact: Reena Bokria at rjb07003@uconn.edu